B. Tang

发表

Peripheral blood neutrophil count as a prognostic factor for patients with hepatocellular carcinoma treated with sorafenib.

Z. Ren, Lan Zhang, Xiaoying Xie, 2017, Molecular and clinical oncology.

Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study

Z. Ren, Lan Zhang, Xiaoying Xie, 2019, BioMed research international.

Survival Benefits and Safety Profile of T ransarterial C hemoembolization (TACE) B ased Monotherapy or Multi-modal Therapies in Locally Advanced Stage Hepatocellular Carcinoma: an Observational Study from Real-World Setting

Feng Zhang, Z. Ren, Lan Zhang, 2019 .

A New Scoring Method for Personalized Prognostic Prediction in Patients with Combined Hepatocellular and Cholangiocarcinoma After Surgery

Meng-Xin Tian, Yinghong Shi, Z. Ren, 2020, Journal of Gastrointestinal Surgery.

Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment

Z. Ren, Lan Zhang, Xin Yin, 2021, Annals of translational medicine.

γ-Glutamyltranspeptidase is a Prognostic Marker of Survival and Recurrence in Radiofrequency-Ablation Treatment of Hepatocellular Carcinoma

S. Ye, Z. Ren, Lan Zhang, 2014, Annals of Surgical Oncology.

ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway

S. Qiu, Z. Ren, Lan Zhang, 2017, Journal of Experimental & Clinical Cancer Research.

ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway

S. Qiu, Z. Ren, Lan Zhang, 2017, Journal of experimental & clinical cancer research : CR.

A Novel Pre-treatment Model Predicting Risk of Developing Refractoriness to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma

Z. Ren, Xin Yin, Miao Li, 2020, Journal of Cancer.

A new substage classification strategy for Barcelona Clinic Liver Cancer stage B patients with hepatocellular carcinoma

Z. Ren, Lan Zhang, Xin Yin, 2019, Journal of gastroenterology and hepatology.

First-Line Systemic Treatment Strategies for Unresectable Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials

Z. Ren, Xin Yin, B. Quan, 2021, Frontiers in Oncology.